Salīdzināt metodes

	RMI: Rivermead Mobility Index	MSFC: Multiplās sklerozes funkcionālais kompozīts
Nozare	Neiroloģija	Neiroloģija
Saime	Process / pipeline	Process / pipeline
Izcelsmes gads	1991	1999
Autors	Frank Collen, Derick Wade, and Rivermead Rehabilitation Centre	Gary Cutter, Richard Rudick, and NMSS Consortium
Tips	Clinician-observed performance test	Clinician-administered performance test
Pirmavots	Collen, F. M., Wade, D. T., Robb, G. F., Bradshaw, C. M. (1991). The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment. International Disability Studies, 13(2), 50-54.	Cutter, G. R., Baier, M. L., Rudick, R. A., et al. (1999). Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Multiple Sclerosis, 5(4), 244-250.
Citi nosaukumi	Rivermead Mobility Index	MS Functional Composite
Saistītās	5	4
Kopsavilkums	The Rivermead Mobility Index (RMI) is a brief, clinician-observed performance test of basic mobility abilities developed for assessing stroke and neurological rehabilitation outcomes. Published in 1991 by Frank Collen and colleagues at Rivermead Rehabilitation Centre (Oxford, UK), the 15-item index measures bed mobility, sitting/standing balance, transfers, and ambulation. The RMI is widely used in stroke units and rehabilitation settings to track functional recovery and predict discharge outcomes.	The Multiple Sclerosis Functional Composite (MSFC) is an objective, performance-based assessment of MS-related disability capturing three key functional domains: lower extremity mobility, upper extremity coordination, and cognitive/processing speed. Developed in 1999 by the National MS Society and adopted widely in clinical trials, the MSFC provides quantifiable endpoints complementing the Expanded Disability Status Scale (EDSS). The three-component design addresses EDSS limitations by including cognition and standardizing measurement via timed tasks.